Similar medications and substitutes for DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT)
In short: Darzalex Faspro (DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT)) belongs to the CD38-directed Cytolytic Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Darzalex Faspro is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Darzalex Faspro in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.